Table II.
Results of TrMab-6 immunostaining in 61 breast cancers.
TrMab-6 | ||||||
---|---|---|---|---|---|---|
Pathological diagnosis | No. of cases | 3+ | 2+ | 1+ | − | No. of positive cases (%) |
Invasive ductal carcinoma | 54 | 26 | 16 | 8 | 4 | 50/54 (92.6) |
Invasive lobular carcinoma | 4 | 1 | 2 | 1 | 0 | 4/4 (100) |
Adenocarcinoma | 2 | 2 | 0 | 0 | 0 | 2/2 (100) |
Medullary carcinoma | 1 | 1 | 0 | 0 | 0 | 1/1 (100) |
Total | 61 | 30/61 (49.2%) | 18/61 (29.5%) | 9/61 (14.8%) | 4/61 (6.6%) | 57/61 (93.4%) |